1. Biosimilars of adalimumab: the upcoming challenge in IBD. (3rd October 2019) Authors: Fiorino, Gionata; Gilardi, Daniela; Correale, Carmen; Furfaro, Federica; Roda, Giulia; Loy, Laura; Argollo, Marjorie; Allocca, Mariangela; Peyrin-Biroulet, Laurent; Danese, Silvio Journal: Expert opinion on biological therapy Issue: Volume 19:Number 10(2019) Page Start: 1023 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Endoscopy after surgery in inflammatory bowel disease: Crohn's disease recurrence and pouch surveillance. (1st September 2020) Authors: Vespa, Edoardo; Furfaro, Federica; Allocca, Mariangela; Fiorino, Gionata; Correale, Carmen; Gilardi, Daniela; Argollo, Marjorie; Zilli, Alessandra; Zacharopoulou, Eirini; Loy, Laura; Danese, Silvio Journal: Expert review of gastroenterology & hepatology Issue: Volume 14:Number 9(2020) Page Start: 829 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Full Interchangeability in Regard to Immunogenicity Between the Infliximab Reference Biologic and Biosimilars CT-P13 and SB2 in Inflammatory Bowel Disease. Issue 3 (16th February 2018) Authors: Fiorino, Gionata; Ruiz-Argüello, M Begoña; Maguregui, Ainara; Nagore, Daniel; Correale, Carmen; Radice, Simona; Gilardi, Daniela; Allocca, Mariangela; Furfaro, Federica; Martínez, Antonio; Danese, Silvio Journal: Inflammatory bowel diseases Issue: Volume 24:Issue 3(2018) Page Start: 601 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Full Interchangeability in Regard to Immunogenicity Between the Infliximab Reference Biologic and Biosimilars CT-P13 and SB2 in Inflammatory Bowel Disease. Issue 3 (16th February 2018) Authors: Fiorino, Gionata; Ruiz-Argüello, M Begoña; Maguregui, Ainara; Nagore, Daniel; Correale, Carmen; Radice, Simona; Gilardi, Daniela; Allocca, Mariangela; Furfaro, Federica; Martínez, Antonio; Danese, Silvio Journal: Inflammatory bowel diseases Issue: Volume 24:Issue 3(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Haematopoietic prolyl hydroxylase‐1 deficiency promotes M2 macrophage polarization and is both necessary and sufficient to protect against experimental colitis. Issue 4 (27th January 2017) Authors: Van Welden, Sophie; De Vos, Martine; Wielockx, Ben; Tavernier, Simon J; Dullaers, Melissa; Neyt, Sara; Descamps, Benedicte; Devisscher, Lindsey; Devriese, Sarah; Van den Bossche, Lien; Holvoet, Tom; Baeyens, Ann; Correale, Carmen; D'Alessio, Silvia; Vanhove, Christian; De Vos, Filip; Verhasselt, ... Journal: Journal of pathology Issue: Volume 241:Issue 4(2017) Page Start: 547 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. IL-23 Blockade for Crohn s disease: next generation of anti-cytokine therapy. (4th May 2017) Authors: Furfaro, Federica; Gilardi, Daniela; Allocca, Mariangela; Cicerone, Clelia; Correale, Carmen; Fiorino, Gionata; Danese, Silvio Journal: Expert review of clinical immunology Issue: Volume 13:Number 5(2017) Page Start: 457 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Lymphatic endothelium contributes to colorectal cancer growth via the soluble matrisome component GDF11. Issue 7 (9th April 2019) Authors: Ungaro, Federica; Colombo, Piergiuseppe; Massimino, Luca; Ugolini, Giovanni Stefano; Correale, Carmen; Rasponi, Marco; Garlatti, Valentina; Rubbino, Federica; Tacconi, Carlotta; Spaggiari, Paola; Spinelli, Antonino; Carvello, Michele; Sacchi, Matteo; Spanò, Salvatore; Vetrano, Stefania; Malesci, ... Journal: International journal of cancer Issue: Volume 145:Issue 7(2019) Page Start: 1913 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. PK, PD, and interactions: the new scenario with JAK inhibitors and S1P receptor modulators, two classes of small molecule drugs, in IBD. (1st September 2020) Authors: Gilardi, Daniela; Gabbiadini, Roberto; Allocca, Mariangela; Correale, Carmen; Fiorino, Gionata; Furfaro, Federica; Zilli, Alessandra; Peyrin-Biroulet, Laurent; Danese, Silvio Journal: Expert review of gastroenterology & hepatology Issue: Volume 14:Number 9(2020) Page Start: 797 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Positioning ustekinumab in moderate-to-severe ulcerative colitis: new kid on the block. (2nd April 2020) Authors: Fiorino, Gionata; Allocca, Mariangela; Correale, Carmen; Roda, Giulia; Furfaro, Federica; Loy, Laura; Zilli, Alessandra; Peyrin-Biroulet, Laurent; Danese, Silvio Journal: Expert opinion on biological therapy Issue: Volume 20:Number 4(2020) Page Start: 421 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Psychological Characteristics of Inflammatory Bowel Disease Patients: A Comparison Between Active and Nonactive Patients. Issue 8 (17th July 2019) Authors: Leone, Daniela; Gilardi, Daniela; Corrò, Bianca E; Menichetti, Julia; Vegni, Elena; Correale, Carmen; Mariangela, Allocca; Furfaro, Federica; Bonovas, Stefanos; Peyrin-Biroulet, Laurent; Danese, Silvio; Fiorino, Gionata Journal: Inflammatory bowel diseases Issue: Volume 25:Issue 8(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗